Please enable JS

Next CRO

NEXT CRO runs clinical trials in Greece, Türkiye and Cyprus, and with its worldwide alliances, offering “plug and play” Study Teams.

 

NEXT CRO is committed to deliver high quality Clinical Trial Services to its customers, meeting high sponsor’s expectations on faster start-up timelines, specific KPIs, and dedicated teams that are accountable to their assignments.

 

Learn more: www.nextcro.eu

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

14th Meeting of the CleanWeb™ Users Club

May 30, 2024

June 18, 2024 – 2:00 PM – 3:00 PM CEST Join us for the 14th meeting of the CleanWeb™ Users Group. This webinar is free and open to all our users. This afternoon traditionally serves as an opportunity to review the latest features developed for our users and to present upcoming developments. During this webinar, […]

READ MORE
telemedecine technologies news

Yes, Agile Can Work in Medtech

May 30, 2024

Med City News Three tips to succeed in a highly regulated environment. Medical devices take multiple years and millions of dollars to bring to market. Regulations play a huge role: medtech manufacturers must meet a range of requirements to get devices approved – or risk wasting their investment. The high cost of failure encourages many […]

READ MORE
telemedecine technologies news

Integrated Biosciences and Illumina Ventures Labs Collaborate on Novel Therapeutics Targeting the Transcriptome

May 30, 2024

BioPharm International The partnership will create therapeutic assets and new discovery platforms and potentially reshape drug discovery. Integrated Biosciences, a biotechnology company that uses synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, announced on May 28, 2024, that it is collaborating with Illumina Ventures Labs to create novel therapeutics targeting the […]

READ MORE